Professional Documents
Culture Documents
Venom From Honeybees Found To Kill Aggres-Sive Breast Cancer Cells
Venom From Honeybees Found To Kill Aggres-Sive Breast Cancer Cells
htm
Follow Subscribe
Your source for the latest research news New: True Size of Prehistoric Mega-Shark
Venom from honeybees found to kill aggres- Most Popular this week
sive breast cancer cells
HEALTH & MEDICINE
Duffy from the Harry Perkins Institute of Medical Research Loss of Smell and Taste Validated
as COVID-19 Symptoms in Patients
and The University of Western Australia, tested the effect of With High Recovery Rate
the venom on the clinical subtypes of breast cancer, includ-
Study Explains Potential Causes for
ing triple-negative breast cancer, which has limited treat- 'Happy Hypoxia' Condition in
COVID-19 Patients
ment options.
LIVING & WELL
Results published in the journal npj Precision Oncology revealed that honey- Boy or Girl? It's in the Father's
bee venom rapidly destroyed triple-negative breast cancer and HER2- Genes
enriched breast cancer cells.
When You're Smiling,
Dr Duffy said the aim of the research was to investigate the anti-cancer the Whole World
Really Does Smile
properties of honeybee venom, and a component compound, melittin, on dif-
With You
ferent types of breast cancer cells.
The 'Gold' in Breast Milk
"No-one had previously compared the effects of honeybee venom or melittin
across all of the different subtypes of breast cancer and normal cells. Strange & Offbeat
"We tested honeybee venom on normal breast cells, and cells from the clini-
cal subtypes of breast cancer: hormone receptor positive, HER2-enriched, HEALTH & MEDICINE
and triple-negative breast cancer. A 400-Year-Old Chamois Will Serve
as a Model for Research on Ice
"We tested a very small, positively charged peptide in honeybee venom
Mummies
called melittin, which we could reproduce synthetically, and found that the Venom from Honeybees Found to
synthetic product mirrored the majority of the anti-cancer effects of honey- Kill Aggressive Breast Cancer Cells
bee venom," Dr Duffy said. Insect Shows Promise as a Good,
Sustainable Food Source
"We found both honeybee venom and melittin significantly, selectively and
rapidly reduced the viability of triple-negative breast cancer and HER2- MIND & BRAIN
enriched breast cancer cells. New Electronic Skin Can React to
Pain Like Human Skin
"The venom was extremely potent," Dr Duffy said.
Sleep Duration, Efficiency and
A specific concentration of honeybee venom can induce 100% cancer cell
Structure Change in Space
death, while having minimal effects on normal cells.
How 'Swapping Bodies' With a
"We found that melittin can completely destroy cancer cell membranes Friend Changes Our Sense of Self
within 60 minutes."
LIVING & WELL
Melittin in honeybee venom also had another remarkable effect; within 20
Using a Public Restroom? Mask Up!
minutes, melittin was able to substantially reduce the chemical messages of
cancer cells that are essential to cancer cell growth and cell division. Evolutionary Theory of Economic
Decisions
"We looked at how honeybee venom and melittin affect the cancer signalling
pathways, the chemical messages that are fundamental for cancer cell 'Drawn-on-Skin' Electronics Offer
Breakthrough in Wearable Monitors
growth and reproduction, and we found that very quickly these signalling
pathways were shut down.
Dr Duffy also tested to see if melittin could be used with existing chemother-
apy drugs as it forms pores, or holes, in breast cancer cell membranes, po-
tentially enabling the entry of other treatments into the cancer cell to en-
hance cell death.
"We found that melittin can be used with small molecules or chemothera-
pies, such as docetaxel, to treat highly-aggressive types of breast cancer.
The combination of melittin and docetaxel was extremely efficient in reduc-
ing tumour growth in mice."
"The bees were put to sleep with carbon dioxide and kept on ice before the
venom barb was pulled out from the abdomen of the bee and the venom ex-
tracted by careful dissection," she said.
While there are 20,000 species of bees, Dr Duffy wanted to compare the ef-
fects of Perth honeybee venom to other honeybee populations in Ireland and
England, as well as to the venom of bumblebees.
"I found that the European honeybee in Australia, Ireland and England pro-
duced almost identical effects in breast cancer compared to normal cells.
However, bumblebee venom was unable to induce cell death even at very
high concentrations.
One of the first reports of the effects of bee venom was published in Nature
in 1950, where the venom reduced the growth of tumours in plants.
However, Dr Duffy said it was only in the past two decades that interest grew
substantially into the effects of honeybee venom on different cancers.
In the future, studies will be required to formally assess the optimum method
of delivery of melittin, as well as toxicities and maximum tolerated doses.
Story Source:
Journal Reference:
RELATED STORIES
New Research Provides Hope for Patients With Hard-to-Treat Breast Cancer
June 13, 2016 — A new way to slow the growth of the most aggressive type
of breast cancer has been identified by scientists, according to a new report.
The work found that using a drug called JQ1 can alter how ...
Below are relevant articles that may interest you. ScienceDaily shares links
with scholarly publications in the TrendMD network and earns revenue from
third-party advertisers, where indicated.
Free Subscriptions
Get the latest science news with ScienceDaily's free email newsletters,
updated daily and weekly. Or view hourly updated newsfeeds in your RSS
reader:
Email Newsletters
RSS Feeds
Follow Us
Keep up to date with the latest news from ScienceDaily via social networks:
Have Feedback?
Leave Feedback
Contact Us
About This Site | Staff | Reviews | Contribute | Advertise | Privacy Policy | Editorial Policy | Terms of Use
Copyright 2020 ScienceDaily or by other parties, where indicated. All rights controlled by their respective owners.
Content on this website is for information only. It is not intended to provide medical or other professional advice.
Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners.
Financial support for ScienceDaily comes from advertisements and referral programs, where indicated.
— CCPA: Do Not Sell My Information — — GDPR: Privacy Settings —